<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN"
"https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
     <Journal>
       <PublisherName>HMP Communications, LLC</PublisherName>
         <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
            <PubDate PubStatus="ppublish">
                <Year>2024</Year>
               <Month>March</Month>
        </PubDate>
        </Journal>
        <ArticleTitle>Combined Rotational excimer lASER coronary atherectomy (RASER) in non-crossable, non-dilatable coronary artery disease: observations from a single center</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00267</ELocationID>
        <Language>EN</Language>
        <AuthorList>
 <Author>
     <FirstName>Kerrick</FirstName>
                <LastName>Hesse</LastName>
                <Affiliation>James Cook University Hospital, Middlesbrough, United Kingdom. Email: Kerrick.hesse@nhs.net</Affiliation>
            </Author>
          <Author>
          <FirstName>Samay</FirstName>
                <LastName>Mehta</LastName>
                <Affiliation>University of Birmingham, United Kingdom</Affiliation>
            </Author> 
          <Author>
          <FirstName>Celine</FirstName>
                <LastName>Tam</LastName>
           <Affiliation>University of Newcastle, United Kingdom</Affiliation>
            </Author>
         <Author>
          <FirstName>Faizan</FirstName>
               <LastName>Ahmed</LastName>
                            <Affiliation>The Freeman Hospital, Newcastle Upon Tyne, United Kingdom</Affiliation>
            </Author>
         <Author>
          <FirstName>Farhan</FirstName>
                <LastName>Shahid</LastName>
                <Affiliation>Queen Elizabeth Hospital, University Hospitals Birmingham, United Kingdom</Affiliation>
            </Author>
       <Author>
          <FirstName>Gary</FirstName>
              <MiddleName>S.</MiddleName>
                <LastName>Mintz</LastName>
                <Affiliation>Cardiovascular Research Foundation, New York, New York, USA</Affiliation>
            </Author>
              <Author>
          <FirstName>Javed</FirstName>
             <MiddleName>M.</MiddleName>
                <LastName>Ahmed</LastName>
                <Affiliation>The Freeman Hospital, Newcastle Upon Tyne, United Kingdom</Affiliation>
            </Author>
</AuthorList>
<Abstract>Background. Balloon non-crossable stenoses represent a challenging subset of coronary artery disease (CAD). They are clinically associated with patients who are older, frailer, and with multi-morbidities, and angiographically with increased tortuosity and coronary artery calcification. Combined rotational (RA) excimer laser coronary atherectomy (ELCA), or RASER, may facilitate stent delivery and deployment in non-crossable, non-dilatable severely calcified lesions. In this study, we assessed preliminary safety and efficacy of the RASER hybrid technique. Methods. RASER feasible percutaneous coronary intervention (PCI) procedures performed at a large tertiary hospital in the northeast of England were retrospectively analyzed from September 1, 2008, to February 28, 2022. Major endpoints were in-hospital death from any cause, as well as procedural and angiographic success, defined by stent delivery with less than 50% residual stenosis and without clinical or angiographic complications, respectively. Results. From 74 unique cases, there were 28 RASER, 24 ELCA/RA, 16 balloon angioplasty Â± stenting, and 6 medically treated patients. In-hospital mortality rate was 5.2%, including 1 ELCA- and 3 RASER-treated patients. Successful stent delivery was achieved in significantly more RASER-treated patients compared to ELCA/RA- or balloon-treated patients: 96.4% (27/28), 25% (6/24), and 31.3% (5/16) respectively (P less than .001). Conclusions. In our retrospective, single-center study, patients with CAD who were deemed appropriate for RASER PCI had a high peri-procedural mortality rate. In this context, adjunctive RASER therapy provides acceptable safety and efficacy as a bailout strategy, with at least 3 out of 5 patients achieving satisfactory procedural and angiographic results. Randomized controlled trials are needed to comprehensively compare the clinical outcomes of high-risk RASER PCI vs conservative medical therapy.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">rotational atherectomy</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">excimer laser coronary atherectomy</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">coronary artery disease</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">percutaneous coronary intervention</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">calcification</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">mortality</Param>
    </Object>
                          </ObjectList>
    </Article>
<Article>
        <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Update on chronic total occlusion percutaneous coronary intervention</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00239</ELocationID>
        <Language>EN</Language>
        <AuthorList>
 <Author>
     <FirstName>Deniz</FirstName>
                <LastName>Mutlu</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Athanasios</FirstName>
                <LastName>Rempakos</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Michaella</FirstName>
                <LastName>Alexandrou</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Ahmed</FirstName>
                <LastName>Al-Ogaili</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Masahisa</FirstName>
                <LastName>Yamane</LastName>
                <Affiliation>Department of Cardiology, Sayama Hospital, Saitama, Japan</Affiliation>
            </Author>
 <Author>
     <FirstName>Khaldoon</FirstName>
                <LastName>Alaswad</LastName>
                <Affiliation>Henry Ford Cardiovascular Division, Detroit, Michigan, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Mir</FirstName>
                <LastName>Basir</LastName>
                <Affiliation>Henry Ford Cardiovascular Division, Detroit, Michigan, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Rhian</FirstName>
                <LastName>Davies</LastName>
                <Affiliation>Wellspan York Hospital, York, Pennsylvania, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>James</FirstName>
                <LastName>Choi</LastName>
                <Affiliation>Texas Health Presbyterian Hospital, Dallas, Texas, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Andrea</FirstName>
                <LastName>Gagnor</LastName>
                <Affiliation>Maria Vittoria Hospital, Torino, Italy</Affiliation>
            </Author>
  <Author>
     <FirstName>Roberto</FirstName>
                <LastName>Garbo</LastName>
                <Affiliation>Maria Pia Hospital, Torino, Italy</Affiliation>
            </Author>
 <Author>
     <FirstName>Omer</FirstName>
                <LastName>Goktekin</LastName>
                <Affiliation>Memorial Bahcelievler Hospital, Istanbul, Turkey</Affiliation>
            </Author>
 <Author>
     <FirstName>Sevket</FirstName>
                <LastName>Gorgulu</LastName>
                <Affiliation>Biruni University Medical School, Istanbul, Turkeyn</Affiliation>
            </Author>
 <Author>
     <FirstName>Jaikirshann</FirstName>
          <MiddleName>J.</MiddleName>
                <LastName>Khatri</LastName>
                <Affiliation>Cleveland Clinic, Cleveland, Ohio, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>William</FirstName>
                <LastName>Nicholson</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Stephane</FirstName>
                <LastName>Rinfret</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Wissam</FirstName>
                <LastName>Jaber</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Mohaned</FirstName>
                <LastName>Egred</LastName>
                <Affiliation>Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK</Affiliation>
            </Author>
  <Author>
     <FirstName>Anastasios</FirstName>
                <LastName>Milkas</LastName>
                <Affiliation>Athens Naval and Veterans Hospital, Athens, Greece</Affiliation>
            </Author>
 <Author>
     <FirstName>Carlo</FirstName>
                <LastName>Di Mario</LastName>
                <Affiliation>Royal Brompton Hospital, London, UK</Affiliation>
            </Author>
 <Author>
     <FirstName>Kambis</FirstName>
                <LastName>Mashayekhi</LastName>
                <Affiliation>University Heart Center Freiburg, Bad Krozingen, Germany</Affiliation>
            </Author>
 <Author>
     <FirstName>Yader</FirstName>
                <LastName>Sandoval</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>M.</FirstName>
        <MiddleName>Nicholas</MiddleName>
                <LastName>Burke</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Emmanouil </FirstName>
         <MiddleName>S.</MiddleName>
                <LastName>Brilakis</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Email: esbrilakis@gmail.com</Affiliation>
            </Author>
                                      </AuthorList>
<Abstract>Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) continues to evolve. This review summarizes recent publications categorized by outcomes, techniques, complications, and ongoing studies in this rapidly growing area.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">chronic total occlusion</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">CTO-PCI</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">percutaneous coronary intervention</Param>
    </Object>
                 </ObjectList>
    </Article>
<Article>
        <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Outcomes following coronary chronic total occlusion revascularization with drug-coated balloons</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/22.00260</ELocationID>
        <Language>EN</Language>
 <AuthorList>
   <Author>
                <FirstName>Mehdi</FirstName>
                <LastName>Madanchi</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland</Affiliation>
            </Author>
   <Author>
                <FirstName>Matthias</FirstName>
                <LastName>Bossard</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland</Affiliation>
            </Author>
   <Author>
                <FirstName>Irena</FirstName>
                <LastName>Majcen</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland</Affiliation>
            </Author>
   <Author>
                <FirstName>Giacomo</FirstName>
                <MiddleName>M.</MiddleName>
                <LastName>Cioffi</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; McMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Canada</Affiliation>
            </Author>
    <Author>
                <FirstName>Francesco</FirstName>
                <LastName>Ferraro</LastName>
                <Affiliation>Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale, Lugano, Switzerland</Affiliation>
            </Author>
     <Author>
                <FirstName>Eleonora</FirstName>
                <LastName>Gnan</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Fondazione IRCCS CÃ  Granda Ospedale Maggiore Policlinico di Milano, University of Milan, Milan, Italy </Affiliation>
            </Author>
     <Author>
                <FirstName>Varis</FirstName>
                <LastName>Gjergjizi</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author>
   <Author>
          <FirstName>Yuan</FirstName>
                <LastName>Zhi</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author>
   <Author>
          <FirstName>Vanessa</FirstName>
                <LastName>Bade</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland</Affiliation>
            </Author>  
   <Author>
          <FirstName>Mathias</FirstName>
                <LastName>Wolfrum</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author> 
     <Author>
          <FirstName>Federico</FirstName>
                <LastName>Moccetti</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author>
       <Author>
          <FirstName>Stefan</FirstName>
                <LastName>Toggweiler</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author>
       <Author>
          <FirstName>Adrian</FirstName>
                <LastName>Attinger-Toller</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland</Affiliation>
            </Author>
       <Author>
          <FirstName>Florim</FirstName>
                <LastName>Cuculi</LastName>
                <Affiliation>Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; 2Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland. Email: florim.cuculi@luks.ch</Affiliation>
            </Author>
                                      </AuthorList>
<Abstract>Objectives. Despite the introduction of improved drug eluting stents (DES), the rate of repeat revascularization procedures following percutaneous coronary interventions (PCI) in coronary chronic total occlusions (CTO) remains high. By leaving vessels uncaged and limiting length of stented segments, drug-coated balloons (DCB) represent an appealing alternative to DES for CTO-PCI. Since data supporting the use of DCBs in CTO-PCI is scarce, we compared the outcomes of patients undergoing CTO-PCI involving DCBs vs DES only. Methods. From 2 prospective registries, outcomes of patients undergoing CTO-PCI involving DCBs and those undergoing PCI with DES only were compared. Outcomes included major adverse cardiac and cerebrovascular events (MACCE) and cardiovascular death (CV-death). Results. Overall, 157 patients were studied; 112 (71%) underwent CTO-PCI involving DCBs and 45 (29%) were treated with DES only. Mean J-CTO score was 1.84 Â± 0.7. Most CTO-lesions involved the right coronary artery, 88 (56%), and 26 (17%) cases were in-stent occlusions. In the DCB group, 46 (41%) lesions were treated with DCBs alone. Mean lengths of the stented segments in the DCB vs DES cohorts were 59 Â± 28 mm vs 87 Â± 37 mm (P less than .001), respectively. After 12 months, the MACCE rate was higher in the DES only vs DCB group (26% vs 11%, P=.03). Length of the stented segment was an independent predictor for MACCE (HR 1.15 [95% CI, 1.05-1.26] per 10-mm stent length). Conclusions. Revascularization of CTO lesions involving DCBs appears safe and potentially lowers MACCE rates compared to treatment with DES alone. Importantly, using DCBs for CTO treatment may reduce total stent length, which determines PCI outcomes.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">drug-coated balloons</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">chronic total occlusion</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">percutaneous coronary intervention</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">drug-eluting stent</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">paclitaxel</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">sirolimus</Param>
    </Object>
              </ObjectList>
    </Article>
<Article>
        <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Coronary physiology instantaneous wave-free ratio (iFR) derived from x-ray angiography using artificial intelligence deep learning models: a pilot study</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00285</ELocationID>
        <Language>EN</Language>
  <AuthorList>
   <Author>
     <FirstName>Miguel</FirstName>
                <LastName>Nobre Menezes</LastName>
                <Affiliation>Structural and Coronary Heart Disease Unit, Cardiovascular Center of the University of Lisbon (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; ServiÃ§o de Cardiologia, Departamento de CoraÃ§Ã£o e Vasos, CHULN Hospital de Santa Maria, Lisbon, Portugal. Email: mnmenezes.gm@gmail.com</Affiliation>
            </Author>
    <Author>
          <FirstName>JoÃ£o</FirstName>
                <LastName>LourenÃ§o Silva</LastName>
                <Affiliation>INESC-ID, Instituto Superior TÃ©cnico, Universidade de Lisboa, Lisbon, Portugal; 4Neuralshift Inc., Lisboa, Portugal</Affiliation>
            </Author>
    <Author>
          <FirstName>Beatriz</FirstName>
                <LastName>Silva</LastName>
                <Affiliation>Structural and Coronary Heart Disease Unit, Cardiovascular Center of the University of Lisbon (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; ServiÃ§o de Cardiologia, Departamento de CoraÃ§Ã£o e Vasos, CHULN Hospital de Santa Maria, Lisbon, Portugal</Affiliation>
            </Author>
    <Author>
          <FirstName>Rita</FirstName>
                <LastName>Marante de Oliveira</LastName>
                <Affiliation>Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal</Affiliation>
            </Author>
      <Author>
          <FirstName>Tiago</FirstName>
                <LastName>Rodrigues</LastName>
                <Affiliation>Structural and Coronary Heart Disease Unit, Cardiovascular Center of the University of Lisbon (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; ServiÃ§o de Cardiologia, Departamento de CoraÃ§Ã£o e Vasos, CHULN Hospital de Santa Maria, Lisbon, Portugal</Affiliation>
            </Author>
      <Author>
          <FirstName>Arlindo</FirstName>
               <MiddleName>L.</MiddleName>
                <LastName>Oliveira</LastName>
                <Affiliation>INESC-ID, Instituto Superior TÃ©cnico, Universidade de Lisboa, Lisbon, Portugal; Neuralshift Inc., Lisboa, Portugal</Affiliation>
            </Author>
    <Author>
          <FirstName>Fausto</FirstName>
           <MiddleName>J.</MiddleName>
                <LastName>Pinto</LastName>
                <Affiliation>Structural and Coronary Heart Disease Unit, Cardiovascular Center of the University of Lisbon (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; ServiÃ§o de Cardiologia, Departamento de CoraÃ§Ã£o e Vasos, CHULN Hospital de Santa Maria, Lisbon, Portugal</Affiliation>
            </Author>
       </AuthorList>
<Abstract>Objectives. Coronary angiography (CAG)-derived physiology methods have been developed in an attempt to simplify and increase the usage of coronary physiology, based mostly on dynamic fluid computational algorithms. We aimed to develop a different approach based on artificial intelligence methods, which has seldom been explored. Methods. Consecutive patients undergoing invasive instantaneous free-wave ratio (iFR) measurements were included. We developed artificial intelligence (AI) models capable of classifying target lesions as positive (iFR â¤ 0.89) or negative (iFR > 0.89). The predictions were then compared to the true measurements. Results. Two hundred-fifty measurements were included, and 3 models were developed. Model 3 had the best overall performance: accuracy, negative predictive value (NPV), positive predictive value (PPV), sensitivity, and specificity were 69%, 88%, 44%, 74%, and 67%, respectively. Performance differed per target vessel. For the left anterior descending artery (LAD), model 3 had the highest accuracy (66%), while model 2 the highest NPV (86%) and sensitivity (91%). PPV was always low/modest. Model 1 had the highest specificity (68%). For the right coronary artery, model 1âs accuracy was 86%, NPV was 97%, and specificity was 87%, but all models had low PPV (maximum 25%) and low/modest sensitivity (maximum 60%). For the circumflex, model 1 performed best: accuracy, NPV, PPV, sensitivity, and specificity were 69%, 96%, 24%, 80%, and 68%, respectively. Conclusions. We developed 3 AI models capable of binary iFR estimation from CAG images. Despite modest accuracy, the consistently high NPV is of potential clinical significance, as it would enable avoiding further invasive maneuvers after CAG. This pivotal study offers proof of concept for further development.</Abstract>
    <ObjectList>
    <Object Type="keyword">
      <Param Name="value">deep learning</Param>
    </Object>
     <Object Type="keyword">
      <Param Name="value">artificial intelligence</Param>
    </Object>
       <Object Type="keyword">
      <Param Name="value">machine learning</Param>
    </Object>
         <Object Type="keyword">
      <Param Name="value">coronary angiography</Param>
    </Object>
         <Object Type="keyword">
      <Param Name="value">coronary artery disease</Param>
    </Object>
       <Object Type="keyword">
      <Param Name="value">percutaneous coronary intervention</Param>
    </Object>
         <Object Type="keyword">
      <Param Name="value">coronary physiology</Param>
    </Object>
           <Object Type="keyword">
      <Param Name="value">fractional flow researve</Param>
    </Object>
         <Object Type="keyword">
      <Param Name="value">instantaneous wave-free ratio (IFR)</Param>
    </Object>
                 </ObjectList>
    </Article>
<Article>
        <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>2</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Racial disparities in chronic total occlusion percutaneous coronary interventions: insights from the PROGRESS-CTO registry</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00274</ELocationID>
        <Language>EN</Language>
        <AuthorList>
<Author>
     <FirstName>Salman</FirstName>
        <MiddleName>S.</MiddleName>
                <LastName>Allana</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA; UT Southwestern Medical Center, Dallas, Texas, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Athanasios</FirstName>
                <LastName>Rempakos</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Michaella</FirstName>
                <LastName>Alexandrou</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Deniz</FirstName>
                <LastName>Mutlu</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Khaldoon</FirstName>
                <LastName>Alaswad</LastName>
                <Affiliation>Henry Ford Cardiovascular Division, Detroit, Michigan, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Lorenzo</FirstName>
                <LastName>Azzalini</LastName>
                <Affiliation>Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Kathleen</FirstName>
                <LastName>Kearney</LastName>
                <Affiliation>Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Oleg</FirstName>
                <LastName>Krestyaninov</LastName>
                <Affiliation>Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia</Affiliation>
            </Author>
 <Author>
     <FirstName>Dmitrii</FirstName>
                <LastName>Khelimskii</LastName>
                <Affiliation>Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation</Affiliation>
            </Author>
 <Author>
     <FirstName>Sevket</FirstName>
                <LastName>Gorgulu</LastName>
                <Affiliation>Acibadem Kocaeli Hospital, Izmit, Turkey</Affiliation>
            </Author>
  <Author>
     <FirstName>Raj</FirstName>
                <LastName>Chandwaney</LastName>
                <Affiliation>Oklahoma Heart Institute, Tulsa, Oklahoma, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Farouc</FirstName>
               <MiddleName>A.</MiddleName>
                <LastName>Jaffer</LastName>
                <Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Jaikirshan</FirstName>
          <MiddleName>J.</MiddleName>
                <LastName>Khatri</LastName>
                <Affiliation>Cleveland Clinic, Cleveland, Ohio, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Rhian</FirstName>
                <LastName>Davies</LastName>
                <Affiliation>Wellspan York Hospital, York, Pennsylvania, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Stewart</FirstName>
                <LastName>Benton</LastName>
                <Affiliation>Wellspan York Hospital, York, Pennsylvania, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>James</FirstName>
        <MiddleName>W.</MiddleName>
                <LastName>Choi</LastName>
                <Affiliation>Texas Health Presbyterian Hospital, Dallas, Texas, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Dimitrios</FirstName>
                <LastName>Karmpaliotis</LastName>
                <Affiliation>Gagnon Cardiovascular Institute, Morristown Medical Center, New Jersey, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Paul</FirstName>
                <LastName>Poommipanit</LastName>
                <Affiliation>University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>William</FirstName>
                <LastName>Nicholson</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Wissam</FirstName>
                <LastName>Jaber</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Stephane</FirstName>
                <LastName>Rinfret</LastName>
                <Affiliation>Emory University Hospital Midtown, Atlanta, Georgia, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Jarrod</FirstName>
                <LastName>Frizzell</LastName>
                <Affiliation>Christ Hospital, Cincinnati, Ohio, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Taral</FirstName>
                <LastName>Patel</LastName>
                <Affiliation>HonorHealth Heart Group Shea, Scottsdale, Arizona, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Brian</FirstName>
                <LastName>Jefferson</LastName>
                <Affiliation>HonorHealth Heart Group Shea, Scottsdale, Arizona, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Nazif</FirstName>
                <LastName>Aygul</LastName>
                <Affiliation>Selcuk University, Konya, Turkey</Affiliation>
            </Author>
 <Author>
     <FirstName>Omer</FirstName>
                <LastName>Goktekin</LastName>
                <Affiliation>Memorial Bahcelievler Hospital, Istanbul, Turkey</Affiliation>
            </Author>
 <Author>
     <FirstName>Ahmed</FirstName>
                <LastName>ElGuindy</LastName>
                <Affiliation>Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt</Affiliation>
            </Author>
 <Author>
     <FirstName>Nidal</FirstName>
                <LastName>Abi-Rafeh</LastName>
                <Affiliation>North Oaks Health System, Hammond, Louisiana, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Bavana</FirstName>
                <MiddleName>V.</MiddleName>
                <LastName>Rangan</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Bilal</FirstName>
                <LastName>Murad</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>M.</FirstName>
           <MiddleName>Nicholas</MiddleName>
                <LastName>Burke</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
 <Author>
     <FirstName>Yader</FirstName>
                <LastName>Sandoval</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA</Affiliation>
            </Author>
  <Author>
     <FirstName>Emmanouil</FirstName>
          <MiddleName>S.</MiddleName>
                <LastName>Brilakis</LastName>
                <Affiliation>Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Email: esbrilakis@gmail.com</Affiliation>
            </Author>
      </AuthorList>
    <Abstract>Objectives. There is limited data on race and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). The authors sought to evaluate CTO PCI techniques and outcomes in different racial groups. Methods. We examined the baseline characteristics and procedural outcomes of 11 806 CTO PCIs performed at 44 US and non-US centers between 2012 and March 2023. In-hospital major adverse cardiac events (MACE) included death, myocardial infarction, repeat target-vessel revascularization, pericardiocentesis, cardiac surgery, and stroke prior to discharge. Results. The most common racial group was White (84.5%), followed by Black (5.7%), âOtherâ (3.9%), Hispanic (2.9%), Asian (2.4%), and Native American (0.7%). There were significant differences in the baseline characteristics between different racial groups. When compared with non-White patients, the retrograde approach and antegrade dissection re-entry were more likely to be the successful crossing strategies in White patients without any significant differences in technical success (86.4% vs 86.4%; P = .93), procedural success (84.8% vs 85.0%; P = .79), and in-hospital MACE (2.0% vs 1.5%; P = .15) between the 2 groups. The technical success rate was significantly higher in the âOtherâ racial group (91.0% vs 86.4% in White, 86.9% in Asian, 84.5% in Black, 84.5% in Hispanic, and 83.3% in Native American; P = .03) without any significant differences in procedural success or in-hospital MACE rates between the groups. Conclusions. Despite differences in baseline characteristics and procedural techniques, the procedural success and in-hospital MACE of CTO PCI were not significantly different between most racial groups.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">CTO-PCI</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">racial disparity in healthcare</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">major adverse cardiac events</Param>
    </Object>
                 </ObjectList>
    </Article>
<Article>
       <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Hot-snare assisted percutaneous mechanical aspiration of a calcified amorphous tumor</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00137</ELocationID>
        <Language>EN</Language>
        <AuthorList>
 <Author>
     <FirstName>Pradyumna</FirstName>
                <LastName>Agasthi</LastName>
                <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA</Affiliation>
            </Author>
          <Author>
          <FirstName>Luke</FirstName>
          <MiddleName>J.</MiddleName>
                <LastName>Burchill</LastName>
                <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA</Affiliation>
            </Author> 
          <Author>
          <FirstName>Jason</FirstName>
          <MiddleName>H.</MiddleName>
                <LastName>Anderson</LastName>
           <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Email: anderson.jason@mayo.edu</Affiliation>
            </Author>
</AuthorList>
<Abstract>A 24-year-old female with history of an atrial septal defect post-patch closure (bovine pericardium) presented 4 years postoperative with an incidentally identified mass originating from the septal patch .</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">mechanical aspiration</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">hot-snare</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">cardiac tumor</Param>
    </Object>
<Object Type="keyword">
      <Param Name="value">right atrial mass</Param>
</Object>
                          </ObjectList>
    </Article>
 <Article>
                <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>The use of a homemade âBAGâ repositioning system to salvage complete coronary stent dislodgement</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00153</ELocationID>
        <Language>EN</Language>
        <AuthorList>
    <Author>
                <FirstName>Siu-Fung</FirstName>
		            <LastName>Wong</LastName>
               <Affiliation>Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China. Email: anthonywaaf1992@hotmail.com</Affiliation>
            </Author>
    <Author>
                <FirstName>Tak-Shun</FirstName>
               <LastName>Chung</LastName>
                <Affiliation>Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China</Affiliation>
            </Author>
      </AuthorList>
    <Abstract>A 71-year-old man who had undergone percutaneous transluminal coronary angioplasty (PTCA) in 2013 was admitted for unstable angina.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">coronary stent dislodgement</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">guide extension</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">small balloon retraction</Param>
    </Object>
                 </ObjectList>
    </Article>
 <Article>
       <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>A unique cause of acute bypass graft failure: think outside the box</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00245</ELocationID>
        <Language>EN</Language>
        <AuthorList>
   <Author>
                <FirstName>Neeraj</FirstName>
		           <LastName>Shah</LastName>
		           <Affiliation>Department of Cardiovascular Disease, East Carolina University, Greenville, North Carolina, USA. Email: neerajshah86@gmail.com</Affiliation>
            </Author>
     <Author>
                <FirstName>Wiley</FirstName>
		           <LastName>Nifong</LastName>
		           <Affiliation>Department of Cardiac Surgery, East Carolina University, Greenville, North Carolina, USA</Affiliation>
            </Author>
      </AuthorList>
      <Abstract>A 62-year-old male presented with non-ST elevation myocardial infarction. Cardiac catheterization revealed multivessel coronary artery disease.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">non-ST elevation myocardial infarction</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">coronary artery bypass graft</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">multivessel coronary artery disease</Param>
    </Object>
                 </ObjectList>
    </Article>
<Article>
                <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Use of chronic total occlusion wiring techniques for extremely angulated side branch access</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00207</ELocationID>
        <Language>EN</Language>
        <AuthorList>
    <Author>
                <FirstName>Siu-Fung</FirstName>
		            <LastName>Wong</LastName>
               <Affiliation>Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China. Email: anthonywaaf1992@hotmail.com</Affiliation>
            </Author>
      <Author>
                <FirstName>Hiu-Cheong</FirstName>
               <LastName>Chow</LastName>
                <Affiliation>Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China</Affiliation>
            </Author>
    <Author>
                <FirstName>Tak-Shun</FirstName>
               <LastName>Chung</LastName>
                <Affiliation>Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China</Affiliation>
            </Author>
      </AuthorList>
    <Abstract>A 75-year-old man was admitted for non-ST-segment elevation myocardial infarction (NSTEMI). </Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">bifurcation</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">chronic total occlusion</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">provisional stenting</Param>
    </Object>
                 </ObjectList>
    </Article>
    <Article>
                <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Snare technique failure in extracting an embolized coronary sinus reducer to the pulmonary artery</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00230</ELocationID>
        <Language>EN</Language>
        <AuthorList>
    <Author>
                <FirstName>Ronan</FirstName>
		            <LastName>Canitrot</LastName>
               <Affiliation>Department of Cardiology, Rangueil University Hospital, Toulouse, France. Email: ronancanitrot@gmail.com</Affiliation>
            </Author>
    <Author>
                <FirstName>Didier</FirstName>
               <LastName>CarriÃ©</LastName>
                <Affiliation>Department of Cardiology, Rangueil University Hospital, Toulouse, France</Affiliation>
            </Author>
      <Author>
                <FirstName>Thibault</FirstName>
               <LastName>Lhermusier</LastName>
                <Affiliation>Department of Cardiology, Rangueil University Hospital, Toulouse, France</Affiliation>
            </Author>
    <Author>
                <FirstName>ClÃ©ment</FirstName>
               <LastName>Servoz</LastName>
                <Affiliation>Department of Cardiology, Rangueil University Hospital, Toulouse, France</Affiliation>
            </Author>
      </AuthorList>
    <Abstract>We report the case of a 79-year-old male patient who benefited from the implantation of a coronary sinus reducer (CSR) (Reducer; Neovasc, Inc.) in the management of typical angina with mild exertion with optimal medical treatment.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">coronary sinus reducer</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">chronic coronary syndrome</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">ischemic heart disease</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">oercutaneous coronary intervention</Param>
    </Object>
      <Object Type="keyword">
      <Param Name="value">refractory angina</Param>
    </Object>
                 </ObjectList>
    </Article>
  <Article>
       <Journal>
            <PublisherName>HMP Communications, LLC</PublisherName>
            <JournalTitle>J Invasive Cardiol</JournalTitle>
            <Issn>1557-2501</Issn>
            <Volume>36</Volume>
            <Issue>3</Issue>
             <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>March</Month>
      </PubDate>
        </Journal>
        <ArticleTitle>Electro-anatomically-guided endomyocardial biopsy in a patient with focal myocardial infiltration and chronic lymphocytic leukemia</ArticleTitle>
<ELocationID EIdType="doi">10.25270/jic/23.00222</ELocationID>
        <Language>EN</Language>
  <AuthorList>
    <Author>
                <FirstName>Maciej</FirstName>
                <MiddleName>T.</MiddleName>
	            	<LastName>Wybraniec</LastName>
		            <Affiliation>First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland; Upper-Silesian Medical Center, Katowice, Poland; Member of the European Reference Network on Heart Diseases - ERN GUARD-HEART. E-mail: maciejwybraniec@gmail.com</Affiliation>
            </Author>
    <Author>
                <FirstName>Marek</FirstName>
	            	<LastName>Grabka</LastName>
	            	<Affiliation>First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland</Affiliation>
            </Author>
   <Author>
                <FirstName>Andrzej</FirstName>
		           <LastName>Hoffmann</LastName>
		           <Affiliation>First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland</Affiliation>
            </Author>
   <Author>
                <FirstName>Romuald</FirstName>
		           <LastName>Wojnicz</LastName>
		           <Affiliation>Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland</Affiliation>
            </Author>
   <Author>
                <FirstName>Katarzyna</FirstName>
		           <LastName>Mizia-Stec</LastName>
		           <Affiliation>First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland; Upper-Silesian Medical Center, Katowice, Poland; Member of the European Reference Network on Heart Diseases - ERN GUARD-HEART</Affiliation>
            </Author>
      </AuthorList>
      <Abstract>A 53-year-old female was admitted to the cardiology department on account of signs and symptoms of congestive heart failure (HF) with severe peripheral edema and dyspnea on exertion (New York Heart Association class III) for the past 3 months.</Abstract>
<ObjectList>
    <Object Type="keyword">
      <Param Name="value">endomyocardial biopsy</Param>
    </Object>
    <Object Type="keyword">
      <Param Name="value">myocardial infarction</Param>
    </Object>
        <Object Type="keyword">
      <Param Name="value">chronic lymphocytic leukemia</Param>
    </Object>
                 </ObjectList>
    </Article>
</ArticleSet>
